CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 3, 2023-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in May:

• BofA Securities 2023 Health Care Conference (Las Vegas, NV): presentation on Wednesday, May 10, 2023 at 2:20 p.m. PT.
• 2023 RBC Capital Markets Global Healthcare Conference (New York, NY): fireside chat on Wednesday, May 17, 2023 at 11:30 a.m. ET.

A live webcast of each event can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230502005905/en/

Investor:
Helen Rubinstein
315-382-3979
helen.rubinstein@sagerx.com

Media:
Matthew Henson
917-930-7147
matthew.henson@sagerx.com

Source: Sage Therapeutics, Inc.